BIOLASE Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts, and Glaucoma

BIOLASE Issued Broad New Patent for Treating Eye Conditions, Including 
Presbyopia, Cataracts, and Glaucoma 
Provides Additional Support for Ophthalmic Applications 
IRVINE, CA -- (Marketwire) -- 02/07/13 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading manufacturer and distributor of dental
lasers, announced today that the U.S. Patent and Trademark Office has
issued BIOLASE a new patent covering the use of its laser
technologies for treating various conditions of the eye.  
Patent 8,366,702 is titled "Methods for Treating Hyperopia and
Presbyopia via Laser Tunneling" and supports the ophthalmic patents
previously granted to BIOLASE by expanding the application of the
laser to include the architecture and techniques for treating an
ocular or related tissue site utilizing laser energy in conjunction
with a measuring device capable of facilitating a determination of
the thickness of anatomical structure. This new patent covers methods
to treat a broad range of eye conditions, including presbyopia,
glaucoma, retinal disorders, and cataracts.  
This is the fourth U.S. patent issued under the "Methods for Treating
Hyperopia and Presbyopia via Laser Tunneling" patent family with an
additional three patents issued internationally. BIOLASE currently
holds a total of 19 issued and 21 pending U.S. and international
patents in seven patent families in the field of ophthalmology. These
patents give BIOLASE and its wholly-owned subsidiary, OCCULASE, Inc.,
the widest range of potential applications and coverage in the field. 
Federico Pignatelli, Chairman and Chief Executive Officer, commented,
"This new patent and those currently under application further
demonstrate how broad the applications are for our patented laser
technologies within ophthalmology. We believe that there is a
tremendous financial opportunity to monetize these assets in
ophthalmology without diluting our focus in continuing to build our
core dental franchise and expanding our position as the world leader
in laser dentistry."  
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures and markets dental lasers and also distributes
and markets dental imaging equipment; products that are focused on
technologies that advance the practice of dentistry and medicine. The
Company's laser products incorporate approximately 290 patented and
patent-pending technologies designed to provide biological treatment
and clinically superior performance with less pain and faster
recovery times. Its imaging products provide cutting-edge technology
at competitive prices to deliver the best results for dentists and
patients. BIOLASE's principal products are dental laser systems that
perform a broad range of dental procedures, including cosmetic and
complex surgical applications, and a full line of dental imaging
equipment and CAD/CAM systems. BIOLASE has sold more than 21,000
lasers.  
Other products under development address ophthalmology and other
medical and consumer markets. 
For updates and information on WaterLase and laser dentistry, find
BIOLASE online at www.biolase.com, Facebook at
www.facebook.com/biolaseinc, Twitter at twitter.com/biolaseinc, and
YouTube at www.youtube.com/biolasevideos.  
For further information, please contact: 
Lisa Wilson 
In-Site Communications, Inc. 
212-759-3929 
 
 
Press spacebar to pause and continue. Press esc to stop.